Clinical Trials for MYD88 Gene Mutation

Find clinical trials for myd88 gene mutation. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies

NCT ID: NCT04994626

This clinical trial is looking at a new treatment approach for patients with a type of blood cancer called diffuse large B-cell lymphoma (DLBCL) that has not responded to previous therapies. Specif...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions